Real-time enrollment status for this respiratory syncytial virus immunization clinical trial
Current Status
Recruiting
Checked: October 28, 2026 at 9:35 PM UTC
| NCT Number | NCT07734649 |
| Recruiting Status | Recruiting |
| Condition | Respiratory Syncytial Virus Immunization |
| Phase | PHASE1 |
| Target Enrollment | 2,400 participants |
| Active Locations | 50 sites in the US |
| Sponsor | Sanofi |
| Last Updated on CT.gov | October 14, 2026 (2 weeks ago) |
As of October 28, 2026: Clinical trial NCT07734649 is currently recruiting participants. This phase1 study for respiratory syncytial virus immunization is actively seeking new participants at 50 locations across the United States. The study is sponsored by Sanofi. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07734649 is actively recruiting participants as of October 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 50 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07734649 was last updated 2 weeks ago (October 14, 2026). HelloStudys verifies this status automatically.